StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
225
This month
3
This year
21
Publishing Date
2024 - 03 - 28
3
2024 - 03 - 27
2
2024 - 02 - 28
2
2023 - 12 - 08
2
2023 - 10 - 25
2
2023 - 07 - 05
2
2023 - 06 - 15
2
2023 - 05 - 31
2
2023 - 05 - 15
3
2023 - 02 - 08
2
2022 - 09 - 13
2
2022 - 08 - 02
2
2022 - 07 - 04
2
2022 - 04 - 13
2
2021 - 08 - 12
3
2021 - 07 - 29
2
2021 - 06 - 25
2
2021 - 06 - 24
2
2021 - 06 - 21
1
2021 - 06 - 17
1
2021 - 06 - 16
1
2021 - 06 - 15
1
2021 - 06 - 09
1
2021 - 06 - 07
1
2021 - 06 - 04
3
2021 - 05 - 24
1
2021 - 05 - 20
1
2021 - 05 - 18
1
2021 - 05 - 17
1
2021 - 05 - 12
1
2021 - 05 - 07
1
2021 - 05 - 06
2
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 22
1
2021 - 04 - 21
1
2021 - 04 - 20
1
2021 - 04 - 19
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 12
1
2021 - 04 - 10
1
2021 - 04 - 09
1
2021 - 04 - 06
1
2021 - 03 - 31
1
2021 - 03 - 25
1
2021 - 03 - 24
1
2021 - 03 - 22
1
2021 - 03 - 19
2
2021 - 03 - 18
1
2021 - 03 - 16
1
2021 - 03 - 12
1
2021 - 03 - 11
2
2021 - 03 - 10
1
2021 - 03 - 09
1
2021 - 03 - 04
1
2021 - 03 - 03
1
2021 - 02 - 10
1
2021 - 01 - 11
1
2018 - 02 - 18
1
Sector
Communications
1
Electronic technology
2
Finance
5
Health services
1
Health technology
225
Manufacturing
10
N/a
4
Process industries
1
Professional, scientific, and technical services
6
Technology services
1
Tags
Agreement
12
Alliances
22
Antiviral
12
Application
9
Approval
16
Bioscience
10
Biotech
9
Biotech-bay
48
Biotech-beach
11
Breast cancer
22
Cancer
59
Chmp
11
Clinical-trials-phase-iii
14
Collaboration
23
Conference
14
Covid
14
Covid-19
16
Disease
20
Drug
25
Earnings
17
Events
20
Fda
21
Fda-approvals
10
Financial
23
Financial results
20
Genetown
12
Global
35
Growth
10
Health
13
Hepatitis
19
Hiv
41
Impact
9
Leukemia
10
License
13
Liver
11
Market
48
Money
9
N/a
225
People
19
Pharma
12
Pharmaceutical
10
Phase 2
9
Phase 3
9
Positive
13
Potential
10
Pre-clinical
9
Preclinical
10
Report
20
Research
54
Results
51
Sciences
30
Study
11
T-cell
32
Technology
9
Therapeutics
42
Therapy
52
Treatment
50
Trial
23
Trodelvy
15
Yescarta
14
Entities
3m company
926
Abb ltd
1433
Abbott laboratories
1571
Abbvie inc.
788
Accenture plc
602
Alphabet inc.
1080
Amgen inc.
571
Apple inc.
1195
Arcelormittal
591
Arrival
4189
Athena consumer acquisition corp.
522
Bank of montreal
543
Becton, dickinson and company
690
Bnp paribas
1740
Broadcom inc.
594
Cisco systems, inc.
899
Cummins inc.
542
Danaher corporation
726
Dell technologies inc.
579
Dow inc.
555
Duke energy corporation
529
Eli lilly and company
1122
Ericsson
1601
Extreme networks, inc.
581
First bank
599
Ford motor company
638
Gartner, inc.
594
General electric company
888
Glaxosmithkline plc
793
Honeywell international inc.
1790
Hubspot, inc.
1400
Infineon technologies ag
533
Intel corporation
947
International business machines corporation
652
Johnson & johnson
2890
Kering
1066
Koninklijke philips n.v.
957
Lithium corp
972
Live nation entertainment, inc.
717
Lockheed martin corporation
576
Medtronic plc
1148
Microsoft corporation
1195
Morgan stanley
3861
Nec corp
522
Nokia corp
980
Nokia corporation
904
Northrop grumman corporation
588
Novartis ag
1119
Oracle corporation
1157
Orange
6878
Panasonic corp
651
Sanofi
2819
Sap se
1479
Snowflake inc.
796
Stellantis n.v
535
Thermo fisher scientific inc
1415
Transunion
527
Verizon communications inc.
1212
Vision sensing acquisition corp.
534
X financial
656
Symbols
ABBV
41
ABEO
2
ABT
7
ACLX
3
ADAP
3
AGTC
2
ALNY
5
ALPMF
3
ALPMY
3
AMGN
31
ASMB
4
ATNX
2
AZN
9
AZNCF
8
BAX
3
BCRX
13
BIIB
6
BLUE
4
BMRN
4
BMY
44
CALT
3
CRSP
3
EDIT
3
GILD
225
GLAXF
17
GLPG
15
GLPGF
12
GMAB
4
GSK
21
HOOK
11
JNCE
16
JNJ
39
LLY
32
NTLA
3
NVO
9
NVS
28
NVSEF
25
OMER
13
OTIC
13
PFE
25
REGN
11
SGMO
4
SNY
55
SNYNF
28
SRNE
4
SRPT
4
SUPN
3
TAK
15
TARA
3
TEVA
3
TEVJF
10
TMO
4
UCBJF
3
UCBJY
3
UTHR
3
VIR
5
VRTX
6
VTRS
5
XERS
10
XLO
3
Exchanges
Amex
1
Nasdaq
225
Nyse
91
Crawled Date
2024 - 03 - 28
3
2024 - 03 - 27
2
2024 - 02 - 28
2
2023 - 12 - 08
2
2023 - 10 - 25
2
2023 - 07 - 05
2
2023 - 06 - 15
2
2023 - 05 - 15
3
2022 - 09 - 13
2
2022 - 08 - 02
2
2022 - 07 - 04
2
2022 - 04 - 13
2
2021 - 08 - 12
3
2021 - 07 - 29
2
2021 - 07 - 08
1
2021 - 07 - 07
1
2021 - 06 - 29
1
2021 - 06 - 25
2
2021 - 06 - 24
2
2021 - 06 - 23
1
2021 - 06 - 22
2
2021 - 06 - 17
1
2021 - 06 - 16
1
2021 - 06 - 15
1
2021 - 06 - 09
1
2021 - 06 - 07
1
2021 - 06 - 04
3
2021 - 05 - 25
1
2021 - 05 - 20
1
2021 - 05 - 18
1
2021 - 05 - 17
1
2021 - 05 - 12
1
2021 - 05 - 07
1
2021 - 05 - 06
2
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 22
1
2021 - 04 - 21
1
2021 - 04 - 20
1
2021 - 04 - 19
1
2021 - 04 - 14
1
2021 - 04 - 13
2
2021 - 04 - 10
1
2021 - 04 - 09
1
2021 - 04 - 06
1
2021 - 03 - 31
1
2021 - 03 - 25
1
2021 - 03 - 24
1
2021 - 03 - 22
1
2021 - 03 - 19
2
2021 - 03 - 18
1
2021 - 03 - 16
1
2021 - 03 - 12
1
2021 - 03 - 11
3
2021 - 03 - 10
1
2021 - 03 - 09
1
2021 - 03 - 04
1
2021 - 03 - 03
1
2021 - 02 - 10
1
2021 - 01 - 11
1
Crawled Time
00:00
12
01:00
10
02:00
2
03:00
3
04:00
3
04:20
1
06:00
3
07:00
3
08:00
3
09:00
2
09:52
1
10:00
3
10:51
1
11:00
22
12:00
15
12:03
1
12:06
1
12:15
9
12:20
6
12:34
1
13:00
7
13:01
1
13:07
1
13:15
1
13:17
1
13:20
4
13:27
1
13:30
1
13:52
1
14:00
11
14:03
2
14:15
2
14:20
3
14:30
2
15:00
5
15:15
1
15:17
1
15:20
1
15:30
2
15:49
1
15:56
1
15:59
1
16:00
6
16:20
2
17:00
8
17:43
1
18:00
7
18:11
1
18:32
1
19:00
4
19:47
1
20:00
14
21:00
9
21:03
1
22:00
11
23:00
6
Source
galmedpharma.com
1
investor.assemblybio.com
1
ir.voyagertherapeutics.com
1
www.fda.gov
19
www.globenewswire.com
79
www.igmbio.com
1
www.nurixtx.com
1
www.prnewswire.com
122
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
N::A
entities :
Gilead sciences, inc.
save search
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
Published:
2024-04-08
(Crawled : 13:30)
- prnewswire.com
RDHL
|
$0.4277
-3.32%
-3.44%
470K
|
Health Technology
|
-18.71%
|
O:
0.57%
H:
0.0%
C:
-1.5%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-3.66%
|
O:
-0.76%
H:
0.72%
C:
0.54%
biopharma
results
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
Published:
2024-04-02
(Crawled : 20:00)
- globenewswire.com
RMD
|
$184.22
2.15%
0.0%
1.2M
|
Health Technology
|
-0.08%
|
O:
0.88%
H:
1.64%
C:
0.03%
LUNG
|
$7.505
1.42%
1.4%
240K
|
Health Technology
|
-11.87%
|
O:
0.59%
H:
1.64%
C:
-7.13%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-7.02%
|
O:
-0.12%
H:
0.24%
C:
-1.54%
financial
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-04-01
(Crawled : 20:00)
- globenewswire.com
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-8.03%
|
O:
-0.08%
H:
0.04%
C:
-1.0%
business
year
pipeline
therapeutics
financial
results
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
News
|
$28.54
-1.48%
-1.51%
560K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
News
|
$289.67
3.83%
5.3K
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
Published:
2024-03-28
(Crawled : 20:00)
- globenewswire.com
ASMB
|
$13.32
0.76%
0.75%
14K
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
Email alert
Add to watchlist
year
financial
results
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
Published:
2024-03-28
(Crawled : 11:00)
- globenewswire.com
XLO
|
$1.06
-3.64%
-3.77%
450K
|
Professional, Scientific, and T...
|
64.32%
|
O:
200.47%
H:
0.52%
C:
-43.75%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-8.19%
|
O:
0.33%
H:
0.85%
C:
0.0%
million
therapeutics
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
Published:
2024-03-28
(Crawled : 11:00)
- globenewswire.com
XLO
|
$1.06
-3.64%
-3.77%
450K
|
Professional, Scientific, and T...
|
64.32%
|
O:
200.47%
H:
0.52%
C:
-43.75%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-8.19%
|
O:
0.33%
H:
0.85%
C:
0.0%
il-12
license
program
agreement
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023
Published:
2024-03-27
(Crawled : 23:00)
- prnewswire.com
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-8.19%
|
O:
0.33%
H:
0.85%
C:
0.0%
year
financial
results
Hepatitis B and C diagnostics market size to increase by USD 2.05 billion, Technavio
Published:
2024-03-27
(Crawled : 14:30)
- prnewswire.com
DHR
|
$253.11
7.21%
0.0%
6.8M
|
Health Technology
|
1.87%
|
O:
0.56%
H:
0.16%
C:
-0.43%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-2.58%
|
O:
1.48%
H:
0.0%
C:
0.0%
VIR
|
$8.13
0.37%
0.37%
770K
|
Health Technology
|
-18.46%
|
O:
0.4%
H:
2.3%
C:
0.9%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-7.43%
|
O:
0.7%
H:
0.19%
C:
0.12%
hepatitis
diagnostics
market
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Published:
2024-03-22
(Crawled : 11:00)
- globenewswire.com
HOOK
|
$0.7801
10.34%
9.37%
790K
|
Health Technology
|
6.34%
|
O:
3.58%
H:
0.0%
C:
-5.19%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-8.29%
|
O:
0.03%
H:
0.16%
C:
-0.68%
pharma
business
year
financial
results
Global Neutropenia Market Poised to Reach USD 5.86 Billion by 2028, Amid Rising Cancer Incidence and Advancements in Treatment Options
Published:
2024-03-18
(Crawled : 00:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.67%
|
O:
-0.02%
H:
0.0%
C:
0.0%
BAX
|
$41.02
1.54%
0.0%
2.6M
|
Health Technology
|
-1.25%
|
O:
0.02%
H:
1.03%
C:
0.96%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-2.02%
|
O:
-1.51%
H:
0.0%
C:
0.0%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-8.5%
|
O:
0.11%
H:
0.59%
C:
0.1%
BIIB
|
$193.18
-0.48%
-0.48%
1.4M
|
Health Technology
|
-11.95%
|
O:
-0.48%
H:
0.31%
C:
0.13%
reach
cancer
treatment
global
market
CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corporate Update
Published:
2024-02-28
(Crawled : 22:00)
- globenewswire.com
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-7.8%
|
O:
0.03%
H:
0.26%
C:
-0.85%
CBAY
|
$32.48
0.03%
8.4M
|
Health Technology
|
0.62%
|
O:
0.02%
H:
0.0%
C:
0.0%
year
update
financial
results
Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights
Published:
2024-02-28
(Crawled : 21:00)
- prnewswire.com
ACLX
|
$54.43
4.67%
4.46%
410K
|
|
-19.13%
|
O:
3.09%
H:
0.94%
C:
-5.16%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-7.8%
|
O:
0.03%
H:
0.26%
C:
-0.85%
business
financial
results
United States Pharmaceuticals Market Size to Surpass US$ 1,068.02 Billion by 2030 | Exhibiting a CAGR of 8.6% Says CoherentMI
Published:
2024-02-22
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
-6.68%
|
O:
0.37%
H:
0.58%
C:
0.58%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-3.83%
|
O:
0.89%
H:
0.4%
C:
0.17%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
-3.97%
|
O:
0.57%
H:
0.47%
C:
-0.58%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-4.56%
|
O:
0.14%
H:
1.01%
C:
0.51%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-4.08%
|
O:
0.29%
H:
0.93%
C:
0.47%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-1.78%
|
O:
0.97%
H:
0.0%
C:
0.0%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-7.9%
|
O:
0.65%
H:
1.35%
C:
0.41%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-4.08%
|
O:
0.47%
H:
2.0%
C:
0.93%
pharmaceuticals
market
Liver Disease Therapeutics Competitive Landscape and Market Forecasts to 2028
Published:
2024-02-12
(Crawled : 20:00)
- prnewswire.com
ALPMY
|
News
|
$9.53
-1.11%
690K
|
Manufacturing
|
-12.29%
|
O:
0.37%
H:
0.74%
C:
0.28%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-1.53%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-2.04%
|
O:
0.8%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
1.86%
|
O:
-0.06%
H:
0.0%
C:
0.0%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-9.97%
|
O:
0.32%
H:
0.11%
C:
-1.55%
ALNY
|
$146.06
0.19%
0.18%
540K
|
Health Technology
|
-13.74%
|
O:
-2.63%
H:
0.98%
C:
-1.75%
liver
disease
therapeutics
market
Assembly Biosciences Announces Effective Date of Reverse Stock Split
Published:
2024-02-08
(Crawled : 13:00)
- globenewswire.com
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-9.93%
|
O:
-0.03%
H:
0.26%
C:
-0.81%
ASMB
|
$13.32
0.76%
0.75%
14K
|
Health Technology
|
1227.27%
|
O:
0.02%
H:
3.0%
C:
-2.49%
Regenerative Medicine Market Worth $49.0 Billion | MarketsandMarkets™.
Published:
2024-01-26
(Crawled : 15:30)
- prnewswire.com
TAK
|
News
|
$13.38
0.15%
0.9%
1.7M
|
Health Technology
|
-8.78%
|
O:
-0.27%
H:
0.38%
C:
0.07%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-7.6%
|
O:
0.29%
H:
0.15%
C:
-0.13%
SRPT
|
$117.065
0.09%
0.09%
440K
|
Health Technology
|
-2.42%
|
O:
0.69%
H:
0.12%
C:
-1.75%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-16.45%
|
O:
0.0%
H:
0.35%
C:
-0.88%
AMGN
|
News
|
$273.69
0.66%
0.65%
2.5M
|
Health Technology
|
-11.84%
|
O:
0.1%
H:
0.47%
C:
0.39%
market
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published:
2024-01-24
(Crawled : 17:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-7.42%
|
O:
0.39%
H:
0.82%
C:
-0.74%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-8.23%
|
O:
0.22%
H:
0.43%
C:
-0.39%
SRNE
|
$0.015
-8.85%
140K
|
Health Technology
|
-66.67%
|
O:
-63.33%
H:
263.64%
C:
127.27%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-15.66%
|
O:
0.1%
H:
0.43%
C:
-0.04%
AUTL
|
$4.5
-1.32%
-1.33%
1.7M
|
Health Technology
|
-18.84%
|
O:
-0.91%
H:
11.52%
C:
4.94%
drug
report
t-cell
global
therapy
market
Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024-2034: Rising Antibiotic Resistance Drives Demand for Pseudomonas Aeruginosa Infection Treatments
Published:
2024-01-17
(Crawled : 02:00)
- prnewswire.com
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-0.26%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-9.29%
|
O:
-1.83%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
-8.2%
|
O:
0.49%
H:
0.18%
C:
0.04%
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-7.57%
|
O:
-1.02%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
3.41%
|
O:
-0.08%
H:
0.1%
C:
-0.18%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
|
-5.19%
|
O:
0.12%
H:
0.77%
C:
0.27%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-8.92%
|
O:
0.45%
H:
0.06%
C:
-0.5%
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-22.05%
|
O:
-0.19%
H:
0.87%
C:
0.76%
report
infection
treatment
global
market
Assembly Biosciences Provides Anticipated Development Milestones for 2024
Published:
2024-01-04
(Crawled : 13:00)
- globenewswire.com
GILD
|
$67.03
0.12%
0.12%
5.2M
|
Health Technology
|
-19.71%
|
O:
0.37%
H:
1.38%
C:
0.82%
ASMB
|
$13.32
0.76%
0.75%
14K
|
Health Technology
|
1535.04%
|
O:
1.84%
H:
0.73%
C:
-2.44%
← Previous
1
2
3
4
5
6
7
8
9
10
11
12
Next →
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.